Cervical Cancer
Cervical cancer is a disease in which cancer cells form in the tissues of the cervix. At City of Hope, our multidisciplinary team pursues an integrated approach to treating cervical cancer by combining the latest research findings with outstanding patient care.
Cervical cancer is a disease in which the cells of the cervix, the lower part of a woman's uterus, become abnormal and grow uncontrollably.
Most cases of cervical cancer are found in women younger than 50 years old. Cervical cancer is rare in women younger than 20.
Many women don't have symptoms of cervical cancer. However, a health care provider may first see signs of cancer during a pelvic exam or a Pap test.
Diagnosing cervical cancer starts with your health care provider asking you questions. They will ask about your medical history, symptoms, risk factors and family history of the disease.
At City of Hope, we offer world-class expertise in standard treatment options, including surgery, radiation therapy and drug therapy, as well as clinical trials, for patients with cervical cancer.
The treatment type used depends on the extent (stage) of cancer and your desire to have children.
Our patients have access to cervical cancer clinical trials, including new chemotherapy, targeted and hormone therapies, surgical techniques, radiation approaches and prevention strategies. These trials give current patients access to promising cervical cancer treatments and improve overall care for future patients worldwide.
At City of Hope, cervical cancer clinicians and researchers collaborate extensively to develop and evaluate new therapies for better survival and quality-of-life outcomes.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after your cervical cancer treatment.
Our Expertise
Our Cervical Cancer Treatment Program Highlights:
- Minimally invasive and robotic surgery, which uses smaller incisions than a traditional open procedure, resulting in less blood loss, reduced pain, shorter recovery time and quicker return to normal activities
- Advanced radiation therapy delivery that is more focused on cancerous cells with less exposure to surrounding normal tissues
- Fertility-preserving therapy options for young women who want to preserve their fertility after cancer treatment
- Individually customized chemotherapy regimens, including novel drugs and drug combinations in our clinical trials program
Your care continues long after treatment completion, and we are committed to helping you and your loved ones manage your recovery. This includes our survivorship program, which has resources to improve the quality of life for our gynecologic cancer survivors.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Cervical Cancer Care Team
Laurie Brunette, MD, is a board-certified gynecologic oncologist who is an expert in surgical cytoreduction of cancer and in the use of minimally invasive surgical techniques, including robotic surgery and fertility-preserving procedures.
Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S., is a board-certified gynecologic oncologist dedicated to offering his patients in Orange County empathy and excellence in clinical care.
Maria de Leon, M.D., is an assistant clinical professor in City of Hope's Division of Gynecologic Oncology, specializing in diagnosis and treatment of cervical, endometrial/uterine and ovarian cancers.
Thanh H. Dellinger, M.D., is a gynecologic oncologist focusing on ovarian cancer, cervical cancer, uterine cancer, robotic surgery and fertility sparing cancer treatments.
Scott Glaser, M.D., is a radiation oncologist and an assistant professor of radiation oncology at City of Hope.
Amy Hakim, M.D., is a surgical oncologist dedicated to treating gynecological cancers. In addition to providing gynecological surgery options to treat cancer, Dr. Hakim is also studying the connection these cancers’ connection to then human papillomavirus (HPV) and the HPV vaccine.
Ernest Han, M.D., Ph.D., is a gynecologic oncologist with specialized training in minimally invasive and robotic-assisted surgery.
Stephen Lee, M.D., is a gynecologic oncologist focusing on ovarian cancer, uterine (endometrial) cancer, cervical cancer, and robotic surgery.
Wei-Chien Michael Lin, M.D., is a gynecologic oncologist at City of Hope's Mission Hills and Santa Clarita, California, locations.